This filing is non-material. Monitor the upcoming conference webcast on September 11 for any new commentary on the ATH434 Phase 3 trial timeline or capital raise plans, which are the key catalysts given the going concern risk disclosed in the 20-F.
Price Chart
Executive Summary
Alterity Therapeutics filed a 6-K announcing CEO David Stamler will participate in a fireside chat at the Cantor Global Healthcare Conference 2026 on September 11, 2026. This is a routine investor relations event with no new clinical data, financial results, or material operational updates. The filing provides no new information beyond what was disclosed in the recent 20-F annual report, which highlighted a going concern risk and an operating loss of $23.4 million for FY2026.
Key Facts
- CEO David Stamler to present at Cantor Global Healthcare Conference 2026 on September 11, 2026 at 10:20 a.m. ET.
- No new clinical data, financial results, or material corporate developments disclosed.
- The filing is a routine conference participation announcement with no stock-moving content.
Financial Impact
No financial impact — routine conference participation announcement.
Risk Factors
- No new information — stock may drift lower with no catalyst.
- Going concern risk from prior 20-F remains unresolved and could weigh on sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-029550 |
| Exhibit: ex_1012294.htm | 0001437749-26-029550 |
| Document: 0001437749-26-029550-index-headers.html | 0001437749-26-029550 |
| Document: 0001437749-26-029550-index.html | 0001437749-26-029550 |
| Document: 0001437749-26-029550.txt | 0001437749-26-029550 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.02 (+3.35%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.02 (−3.35%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.02 (−3.35%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.02 (−15.48%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.02 (−15.48%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.02 (−16.87%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.02 (−35.26%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.02 (−37.27%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.02 (−37.27%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.02 (−44.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers